Adeia ADEA 深 沪
等待开盘 02-11 09:30:00 美东时间
19.24
+0.040
+0.21%
华盛通- 最 高19.60
- 今 开19.27
- 成交量 65.64万股
- 最 低 19.05
- 昨 收 19.20
- 总市值 21.07亿
- 52周最高 20.33
- 市盈率 静 33.66
- 换手率 0.60%
- 52周最低 10.44
- 委 比 23.80%
- 总股本 1.10亿
- 历史最高 27.41
- 量 比 0.76
- 振 幅 2.86%
- 历史最低 0.22
- 每 手 1
- 风险率 2.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Adeia Expands Executive Leadership Team
BRIEF-Adeia Expands Executive Leadership Team Jan 26 (Reuters) - Adeia Inc ADEA.O : ADEIA EXPANDS EXECUTIVE LEADERSHIP TEAM TO ACCELERATE GROWTH AND ADVANCE SEMICONDUCTOR STRATEGY Source text: ID:nGNX1lz4Ql Further company coverage: ADEA.O (( Reuters.Briefs@thomsonreuters.com ;))
01-27 05:40
Adeia Inc. Appoints Mark Kokes as Chief Revenue Officer and Bill Thomas as Chief Strategy Officer
Adeia Inc. Appoints Mark Kokes as Chief Revenue Officer and Bill Thomas as Chief Strategy Officer Adeia Inc. has expanded its executive leadership team with new appointments to support its growth strategy. Dr. Mark Kokes has been named chief revenue officer, responsible for global sales and manageme
01-27 05:10
Adeia to Release Fourth Quarter 2025 Financial Results on February 23, 2026
Adeia Inc. will announce its Q4 2025 financial results on February 23, 2026, followed by an earnings conference call at 2:00 p.m. PT (5:00 p.m. ET). Call details and a webcast link are provided for U.S. and international participants. A replay of the webcast and telephonic replay will be available for future access. Adeia is an R&D and IP licensing company focused on innovation in media and semiconductor industries.
01-21 21:05
美股大行评级 | 潜在涨幅908.06%！Piper Sandler首予Palisade Bio(PALI)"超配"评级，目标价25美元
今日重点评级关注：Needham：维持Autolus Therapeutics"买入"评级，目标价从10美元升至11美元；BTIG：维持Praxis Precision Medicine"买入"评级，目标价从507美元升至843美元
2025-12-30 10:04
美股周涨跌榜 | 奥麦罗制药周涨近64%！关键药物获FDA批准；矿业股HYMC周涨逾52%
奥麦罗制药周涨近64%！关键药物获FDA批准；矿业股HYMC周涨逾52%，此前宣布高品位银钻探结果；德纳维制药周涨近42%，获制药巨头赛诺菲安万特收购>>
2025-12-27 09:57
美股大行评级 | 潜在涨幅63.56%！拜玛林制药获Truist Securities升目标价至100美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持拜玛林制药"买入"评级，目标价从80美元升至100美元；HC Wainwright & Co.：维持Savara"买入"评级，目标价从8美元升至10美元
2025-12-24 11:17
美股牛股 | 金银生产商HYMC涨超49%，于钻探计划中发现了高品位银；Velo3D涨44%
金银生产商HYMC涨超49%，于钻探计划中发现了高品位银；Velo3D涨44%，获美国国防部3260万美元的合同；量子计算概念股QBTS涨20%>>
2025-12-23 14:54
美股大行评级 | 潜在涨幅498.16%！SurgePays Inc获Ascendiant Capital升目标价至9.75美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持SurgePays Inc"买入"评级，目标价从9.5美元升至9.75美元；Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从8美元升至10美元
2025-12-23 12:32
Rosenblatt Maintains Buy on Adeia, Raises Price Target to $20
Rosenblatt analyst Kevin Cassidy maintains Adeia (NASDAQ:ADEA) with a Buy and raises the price target from $17 to $20.
2025-12-23 02:30
Adeia Strikes Long-Term Disney Deal, Ends Legal Fight, Lifts Outlook
Adeia announces long-term licensing deal with Disney, ending legal disputes. Raises 2025 financial outlook due to strong momentum.
2025-12-22 23:04
